Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Centessa Pharmaceuticals PLC Sponsored ADR (CNTA) had Operating Cash Flow per Share of $-0.43 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$15.00M |
|
$-26.14M |
|
-- |
|
$15.00M |
|
$45.78M |
|
$-30.78M |
|
$6.04M |
|
$-24.74M |
|
$-24.74M |
|
$-26.14M |
|
$-26.14M |
|
$-26.14M |
|
$-26.14M |
|
$-30.78M |
|
$-32.33M |
|
133.03M |
|
133.03M |
|
$-0.20 |
|
$-0.20 |
|
| Balance Sheet Financials | |
$347.72M |
|
$0.68M |
|
$180.13M |
|
$527.85M |
|
$24.20M |
|
$109.25M |
|
$117.40M |
|
$141.60M |
|
$386.25M |
|
$386.25M |
|
$386.25M |
|
133.55M |
|
| Cash Flow Statement Financials | |
$-57.25M |
|
$-222.39M |
|
$3.09M |
|
$383.22M |
|
$105.16M |
|
$-278.06M |
|
$7.88M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.37 |
|
-- |
|
-- |
|
0.22 |
|
0.28 |
|
100.00% |
|
-205.18% |
|
-205.18% |
|
-- |
|
-164.92% |
|
-174.23% |
|
$-57.25M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
0.30 |
|
297.65 |
|
-6.77% |
|
-6.77% |
|
-4.95% |
|
-5.27% |
|
$2.89 |
|
$-0.43 |
|
|
Operating Cash Flow per Share |
$-0.43 |